Investment
Features
FeesSafety
Academy
More
Pluang+

Compare OneSpan Inc (OSPN) vs Tilray Brands Inc (TLRY) Price & Performance

OneSpan IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

OneSpan Inc vs Tilray Brands Inc — how do they compare? OneSpan Inc trades at $15.2 (market cap $571.66M), while Tilray Brands Inc trades at $4.19 (market cap $524.07M). The key difference: OneSpan Inc and Tilray Brands Inc are close in size by market cap, and OneSpan Inc pays a 3.37% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

OSPNTLRY
Market Cap
$571.66M$524.07M
Sector
TechnologyHealth
52-Week High
$16.32$21.00
52-Week Low
$10.15$4.23
Enterprise Value
$529.87M$621.22M
Dividend Yield
3.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

OneSpan Inc

OneSpan (OSPN) trades at $15.51, up 0.26% on the day, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a 28.47% net income margin and a low P/E of 8.57, indicating potential undervaluation. Recent earnings have consistently beaten expectations, and the company announced a $0.13 dividend for H1 2026. Analyst sentiment is positive with a 66.7% buy rating, though the consensus price target of $13.50 is below the current price.

The outlook for OSPN is cautiously optimistic, supported by solid fundamentals and positive earnings momentum. Key opportunities include attractive valuation and consistent profitability. Risks include negative net cash flow trends and competitive pressures in the cybersecurity sector. Investors should weigh the strong analyst buy sentiment against the below-consensus price target.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About OneSpan Inc

OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.

Read more on OSPN

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY